疝修补术后补片植入与自身免疫病发病率的全国性回顾性队列研究
经倾向性评分匹配后两组各1500例,随访期间新发AID发病率无统计学差异(补片组1.1% vs 对照组1.5%,P=0.520)。结论认为补片植入不增加中期发生AID的风险。
要点
- 补片植入与非补片手术后新发自身免疫病发病率无统计学差异。
- 匹配后补片组AID发病率为1.1%,对照组为1.5%(P=0.520)。
- 研究结果可为患者关于补片相关自身免疫风险的担忧提供 reassurance。
核心结论
- 基于该队列研究,补片植入不增加中期发生自身免疫病的风险。
研究设计与样本
- 采用倾向性评分匹配年龄、性别和社会经济地位以减少选择偏倚,匹配后两组各1500例。
主要发现
- 匹配后随访期间新发AID发病率在补片组为1.1%,对照组为1.5%,差异无统计学意义(P=0.520)。
临床怎么用
- 研究结果可用于告知患者补片植入不增加中期自身免疫病风险,促进知情决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Some patients report experiencing various systemic symptoms after surgical placement of a (polypropylene (PP)) mesh implant, including fatigue, arthritis, and myalgia. As these complaints could resemble systemic symptoms of autoimmune disease (AID), there are concerns that mesh implants could induce such disorders. The aim of this study was to identify the incidence of AID after mesh implantation, compared with controls in whom no mesh was implanted. METHODS: In this national retrospective cohort study, approximately 4 million people insured with Dutch health insurer Coöperatie VGZ were screened for operative procedure reimbursements for inguinal and incisional hernia repair, between January 2015 and January 2019. Patients who underwent cholecystectomy were included as controls, as no mesh is implanted during this procedure. Patients were followed from 2 years before surgery to 3 years after surgery. The primary outcome was the difference in the incidence of AID after mesh implantation, compared with surgery without mesh. Propensity score matching for age, sex, and socioeconomic status was performed to reduce selection bias. RESULTS: The cohort included 19 464 inguinal/incisional hernia patients (86.0% male) and 18 259 cholecystectomy patients (31.8% male). After matching, both groups consisted of 1500 patients. The incidence of new AID during follow-up was not statistically different between the two groups (1.1% for the intervention group and 1.5% for the control group; P = 0.520). CONCLUSION: Based on this cohort study, mesh implants do not increase the medium-term risk of developing AID. WHAT IS ALREADY KNOWN: Inguinal and incisional hernia repairs are common operations. Polypropylene mesh is frequently used in hernia repair as it reduces risk of hernia recurrence. However, some concern exists about a potential association between mesh implants and autoimmune diseases. Consequently some patient groups have called for mesh-free options to be offered. Legal claims for compensation have been brought by some patients treated with mesh who have developed autoimmune diseases. WHAT IS NEW: This study compared the incidence of autoimmune diseases in patients undergoing hernia repair with mesh versus those undergoing cholecystectomy (without mesh). The findings demonstrate that mesh use is not associated with a higher incidence of autoimmune diseases. Potential impact on future practice: By providing evidence that mitigates fears about mesh-related autoimmune issues, this research can reassure patients and promote informed decision-making, potentially leading to a reduction in litigation related to hernia mesh procedures.
引用
- Gielen MJCAM, Chaoui AM, Schoenmakers S, et al. Incidence of autoimmune disease after hernia surgery with a mesh implant: national retrospective cohort study. Br J Surg. 2026. PMID: 42095834. doi:10.1093/bjs/znag025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。